Dupont Capital Management Corp Aerie Pharmaceuticals Inc Transaction History

Dupont Capital Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 29, 2020	SELL	$11.84 - $25.52 $170,756 - $368,049	-14,422 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$18.41 - $28.0 $63,017 - $95,844	-3,423 Reduced 19.18%	14,422 $277,000
Q2 2019 Jul 30, 2019	BUY	$28.97 - $48.21 $88,300 - $146,944	3,048 Added 20.6%	17,845 $527,000
Q1 2019 Apr 30, 2019	BUY	$36.32 - $49.25 $537,427 - $728,752	14,797 New	14,797 $703,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.